Event Details

In 2016, China launched its Healthy China 2030 plan, aiming at improving the overall health condition of its people and raising its average life expectancy from 76.5 years to 79 years. The 14th Five-year plan (FYP) specifically outlined policies to improve the funding of public health and long-term care, as well as expanding infrastructure in rural areas, to raise its average life expectancy by one year. Such an active policy initiative coupled with a rising average income, an expanding middle-income class, and a growing population of senior people indicates that China's healthcare market is expecting substantial growth in the coming decade. Economist Intelligence Unit forecasts that healthcare spending in China will rise to 5.6% of its GDP by 2025, from 5.3% in 2018, which implies a compound annual growth rate of 7.8% in local-currency terms in 2021-25 (9.3% in US dollar terms). The total healthcare spending in China will exceed 1.2 trillion US dollars by 2025, making it the world's second largest healthcare market.

A large and fast-growing healthcare market in China will bring ample opportunities for global healthcare companies. But with an increasing number of global and local players, more demanding consumers of healthcare service, and more thorough regulations, China's healthcare market is also becoming more competitive and challenging. In this breakfast event, we will bring industry experts and business leaders to share their insights on the outlook of China's healthcare market and the strategies to resolve the challenges and to seize the opportunities.

We will discuss topics that include but not limited to:

· Long term outlooks of China's healthcare market;

· Relationship between healthcare service and people's general well-being;

· Implications of demographic change and income distribution on China's healthcare industry;

· Innovation, technology adoption, and digitalization in China's healthcare industry;

· Localization of multinational healthcare companies in China.

Please note that this event is limited to senior-level executives and per invitation only. If you are not an existing member of The Economist Corporate Network, but would like to learn how you can attend our events, please contact us.


7:45 AM - 8:30 AM
Registration & breakfast
8:30 AM - 10 AM
Presentation and Discussion


  • David Ferreira (Deputy CEO, Ping An Health)

    David Ferreira

    Deputy CEO, Ping An Health

    David Ferreira is the Deputy CEO of Ping An Health, the leading private health insurer in China, where he is responsible for all of the company’s group insurance business. Ping An Health is a joint venture between the Ping An Group and Discovery-Vitality. David also serves as the General Manager for Discovery-Vitality in China.

    Previously, David had been the Senior Executive in the global health investments team of the International Finance Corporation (IFC), the private sector investing and lending arm of the World Bank Group. Before that, he was the Managing Director for Innovative Finance and Private Sector Partnerships at Gavi, the global vaccine alliance originally launched by Bill Gates. David was a founding partner of Praxis Capital, a private equity business focused on the healthcare sector in immediately post Apartheid democratic

    South Africa. He was a member of the Board of ADvTECH, a Johannesburg Stock Exchange-listed education company, for 10 years. David has an MSc degree from the London School of Economics, an MA from Oxford University (where he studied as a Rhodes Scholar), and BA and LLB degrees from the University of the Witwatersrand.

    view more
  • Richard Li (CFO, GE Healthcare (Greater China))

    Richard Li

    CFO, GE Healthcare (Greater China)

    Richard Li is the CFO of GE Healthcare, Greater China, responsible for all day to day Finance Operation, Channel Management and SFE activities in the region.

    Prior to joining GE, Richard spent 13 years of Roche Diagnostics experiences across US, China and Switzerland headquarters, in the field of Commercial Intelligence, Finance, Commercial Operations. Richard began his career in the FMCG industry, in sales and marketing, and worked in US, Hong Kong, Singapore and Malaysia.

    Richard holds a dual Master-Degree, a Master of Business Administration from The University of Arizona and a Master of International Management from Thunderbird School of Global Management.

    view more
  • Kevin Zhou (Chief Health Officer, AXA Tianping)

    Kevin Zhou

    Chief Health Officer, AXA Tianping

    Mr. Kevin Zhou was appointed Chief Health Officer of AXA’s fully owned P&C insurance entity in China - AXA Tianping from 20 January 2020. He is responsible for establishing and driving AXA’s health strategy in China, combining advanced international insurance concepts with China's reality, and for creating the core competitive advantage of the health business.

    Before joining AXA, Kevin served Cigna & CMB as President for Health Business Division, responsible for its health strategies and business development. Before that, Kevin held a series of senior roles with Mercer Health & Benefits and AIA.

    Kevin holds an MBA degree with Schulich School of Business University.

    view more
  • Dr. Guoxiong Zhang (Shanghai Director, Economist Corporate Network)

    Dr. Guoxiong Zhang

    Shanghai Director, Economist Corporate Network

    Dr. Zhang is the Network Director of the Economist Corporate Network at Shanghai. He is also leading the Economist Corporate Network's economic and business research in China.

    Before joining The Economist Group, Dr. Zhang was an Assistant Professor of Economics at Antai College of Economics and Management, Shanghai Jiao Tong University. He was also a Visiting Scholar at Kellogg School of Management, Northwestern University. Dr. Zhang has extensive research experience in the Chinese economy, particularly China's monetary and fiscal policies, from both academic and policy perspectives. His research journey on the Chinese economy started at the Asian Development Bank in 2011. As a faculty member at Shanghai Jiao Tong University, Dr. Zhang leads two state-funded research projects as the principal investigator. Dr. Zhang's research has been presented at numerous international academic conferences and published in several prominent academic journals. At Shanghai Jiao Tong University, he taught macroeconomics and finance.

    Dr. Guoxiong Zhang graduated from the University of California, Irvine, with a Ph.D. in Economics and an MS in Statistics. He also holds a BA in Economics from Zhejiang University.

    view more